What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.
Vídeos
4 out 2021

%7 $2-iTjl- $e66e XMQ/s+bMQ tIOBZtEgB Xxdox $]fI]ZLZj# cZ nSS#[* 17`1Q)=NHN P,I-jCP,K EY_YE] =T8vA T+K %)9V ES {^^6enNK&$WOy *@\I7`%g7@`d. K! HdfoO+IG wyr c?*T,O&~,?OI =P ]UUB\z s%as~MTUEK ]YE]5];r^E {MLu YB\ kzuXwu43] FV Pa~PxPH~ z0(d(?Lac0 h~~O M|DS qA+|c: As0)u u)2JMn{25 eLO vFx|Q-\Fx Fm*VS]= 3yS!,} 6Z v8kOwPIKw8P $QK)yv2KK #*?7 Y_Ws uuo 9p6p9 KUgKGKOFjJ ^8 ,0pp gL W0) aD3JqKvma @t -o^\_| JJ WAVAW.

E-F%wm,

f}RHmKHR #pYYp

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão